(Q33724677)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470557%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

review article

1 reference

title

Pharmacokinetics and pharmacodynamics of antibiotics in meningitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470557%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

0 references

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470557%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

author name string

W A Craig

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470557%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470557%20AND%20SRC:MED&resulttype=core&format=json

Infectious Disease Clinics of North America

12 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470557%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470557%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470557%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

page(s)

595-618

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470557%20AND%20SRC:MED&resulttype=core&format=json

Cefotaxime diffusion into cerebrospinal fluid of children with meningitis

12 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Cerebrospinal fluid penetration of amikacin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Intravenous cefotaxime in children with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Human cerebrospinal fluid pharmacokinetics and treatment of bacterial meningitis with ceftizoxime

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Concentrations of cefoperazone in cerebrospinal fluid during bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Diffusion of ceftriaxone into the cerebrospinal fluid of adults

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Comparison of ceftriaxone and traditional therapy of bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostat

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Treatment of bacterial meningitis with once daily ceftriaxone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Pharmacokinetics of cefuroxime in infants and children with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Clinical evaluation of piperacillin with observations on penetrability into cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Evidence of active transport of benzyl-14C-penicillin from cerebrospinal fluid to blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Penetration of aztreonam into cerebrospinal fluid of patients with and without inflamed meninges

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Blood-Brain and CSF Barriers to Penicillin and Related Organic Acids

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Penetration of ceftazidime into the cerebrospinal fluid of patients with and without evidence of meningeal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Nafcillin entry into human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Penetration of sulbactam and ampicillin into cerebrospinal fluid of infants and young children with meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Cefoxitin penetration into cerebrospinal fluid in patients with purulent meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

The treatment of neonatal meningitis due to gram-negative bacilli with ciprofloxacin: evidence of satisfactory penetration into the cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Penetration of aztreonam into human cerebrospinal fluid in the presence of meningeal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Use of ampicillin-sulbactam for treatment of experimental meningitis caused by a beta-lactamase-producing strain of Escherichia coli K-1

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

A pharmacologic evaluation of penicillin in children with purulent meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Cefoxitin concentrations in the cerebrospinal fluids of patients with meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Cerebrospinal fluid penetration of imipenem and cilastatin (primaxin) in children with central nervous system infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Pharmacokinetics and antibacterial efficacy of cefpirome (HR 810) in experimental Escherichia coli and Haemophilus influenzae type b meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Comparative activity of twelve beta-lactam drugs tested against penicillin-resistant Streptococcus pneumoniae from five medical centers: effects of serum protein and capsular material on potency and spectrum as measured by reference tests

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Penetration of the blood brain barrier by metronidazole and tinidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Clinical Pharmacology of Cefotaxime in Pediatric Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Aminoglycoside Therapy of Gram-Negative Bacillary Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Evaluation of piperacillin-tazobactam in experimental meningitis caused by a beta-lactamase-producing strain of K1-positive Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Treatment of acute purulent meningitis with tetracycline

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Evaluation of cefamandole therapy of patients with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Effect of meningitis and probenecid on the penetration of vancomycin into cerebrospinal fluid in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Ceftriaxone diffusion into cerebrospinal fluid of children with meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Vancomycin penetration of a brain abscess: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Penetration of Cefoxitin into Human Cerebrospinal Fluid: Comparison with Cefamandole, Ampicillin, and Penicillin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Antibiotic pharmacodynamics in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Simulation of human serum pharmacokinetics of ticarcillin-clavulanic acid and ceftazidime in rabbits, and efficacy against experimental Klebsiella pneumoniae meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Penetration of ceftazidime into cerebrospinal fluid of patients with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Penetration of aztreonam into cerebrospinal fluid of patients with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

The penetration of cefuroxime into the cerebrospinal fluid through inflamed and non-inflamed meninges

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Lipophilicity at pH 7.4 and molecular size govern the entry of the free serum fraction of drugs into the cerebrospinal fluid in humans with uninflamed meninges

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Rifampin for therapy of experimental pneumococcal meningitis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Concentration of Cefuroxime in Cerebrospinal Fluid in Patients with Bacterial Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Treatment of bacterial meningitis with ceftizoxime

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Postantibiotic effect of trovafloxacin against gram-positive and -negative organisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Diffusion of ofloxacin into cerebrospinal fluid of patients with purulent meningitis or ventriculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Bactericidal and Bacteriostatic Action of Chloramphenicol Against Meningeal Pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Fine structural localization of a blood-brain barrier to exogenous peroxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Mecillinam alone and in combination with ampicillin or moxalactam in experimental escherichia coli meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Mecillinam-Ampicillin Synergism in Experimental Enterobacteriaceae Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Comparison of cefoperazone with penicillin, ampicillin, gentamicin, and chloramphenicol in the therapy of experimental meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Drug delivery to the central nervous system: general principles and relevance to therapy for infections of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Effect of methylprednisolone on entry of ampicillin and gentamicin into cerebrospinal fluid in experimental pneumococcal and Escherichia coli meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Response to Therapy in an Experimental Rabbit Model of Meningitis Due to Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Comparison of Netilmicin with Gentamicin in the Therapy of Experimental Escherichia coli Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Co-trimoxazole versus nafcillin in the therapy of experimental meningitis due to Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Quinolone therapy for infections of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Pharmacodynamics of antibiotics in the therapy of meningitis: infection model observations

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Cefuroxime treatment of bacterial meningitis in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Ceftriaxone transport through the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Inhibition of Penicillin Transport from the Cerebrospinal Fluid after Intracisternal Inoculation of Bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Pharmacokinetics of Ceftriaxone in Pediatric Patients With Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Comparison of ceftriaxone with standard therapy for bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Penetration of cefamandole into spinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Pharmacokinetics and bacteriological efficacy of ticarcillin-clavulanic acid (timentin) in experimental Escherichia coli K-1 and Haemophilus influenzae type b meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Influence of antibiotic dose, dosing interval, and duration of therapy on outcome in experimental pneumococcal meningitis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

The postantibiotic effect in the treatment of experimental meningitis caused by Streptococcus pneumoniae in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Antibacterial Activity of -Lactam Antibiotics in Experimental Meningitis Due to Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Pharmacological study of cefazolin during intermittent and continuous infusion: a crossover investigation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Evaluation of vancomycin for therapy of adult pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Ventricular cerebrospinal fluid concentrations of trimethoprim-sulphamethoxazole

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Ampicillin in Haemophilus influenzae meningitis. Clinicopharmacologic evaluation of intramuscular vs intravenous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Diffusion of cefpirome into the cerebrospinal fluid of patients with purulent meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Penetrance of nafcillin into human ventricular fluid: correlation with ventricular pleocytosis and glucose levels

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Intraventricular levels of amikacin after intravenous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

Effect of pooled human cerebrospinal fluid on the postantibiotic effects of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970096-9

7 January 2021

10.1016/S0891-5520(05)70096-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10470557%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference